Literature DB >> 20527889

Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.

Michael Palucki1, John D Higgins, Elizabeth Kwong, Allen C Templeton.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20527889     DOI： 10.1021/jm1002638

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  7 in total

1.  Predicting drug substances autoxidation.

Authors:  P Lienard; J Gavartin; G Boccardi; M Meunier
Journal:  Pharm Res       Date:  2014-08-13       Impact factor: 4.200

2.  Oral bioavailability of a poorly aqueous drug from three different SBE7-β-cyclodextrin based formulations in beagle dogs.

Authors:  René Holm; Lene Andresen; Claus Strange
Journal:  Results Pharma Sci       Date:  2011-10-08

3.  Introduction: use of radioactive compounds in drug discovery and development.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-02-10       Impact factor: 3.739

4.  Salts and Polymorph Screens for Bedaquiline.

Authors:  Mercy Okezue; Susan Bogdanowich-Knipp; Daniel Smith; Matthias Zeller; Stephen Byrn; Pamela Smith; Dale K Purcell; Kari Clase
Journal:  AAPS PharmSciTech       Date:  2021-08-25       Impact factor: 3.246

5.  Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO Micro Infusion Pump: Programmable, Refillable, and Implantable.

Authors:  Tsung Tan; Stephanie W Watts; Robert Patrick Davis
Journal:  Front Pharmacol       Date:  2011-07-29       Impact factor: 5.810

Review 6.  Molecular Simulation and Statistical Learning Methods toward Predicting Drug-Polymer Amorphous Solid Dispersion Miscibility, Stability, and Formulation Design.

Authors:  Daniel M Walden; Yogesh Bundey; Aditya Jagarapu; Victor Antontsev; Kaushik Chakravarty; Jyotika Varshney
Journal:  Molecules       Date:  2021-01-01       Impact factor: 4.411

7.  Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates.

Authors:  Hannes Lengauer; Damjan Makuc; Damjan Šterk; Franc Perdih; Arthur Pichler; Tina Trdan Lušin; Janez Plavec; Zdenko Časar
Journal:  Pharmaceutics       Date:  2020-04-10       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.